Results 251 to 260 of about 2,787,448 (332)
Machine Learning of Endoscopy Images to Identify, Classify, and Segment Sinonasal Masses
ABSTRACT Background We developed and assessed the performance of a machine learning model (MLM) to identify, classify, and segment sinonasal masses based on endoscopic appearance. Methods A convolutional neural network‐based model was constructed from nasal endoscopy images from patients evaluated at an otolaryngology center between 2013 and 2024 ...
Lirit Levi+10 more
wiley +1 more source
Watching the Barn Door Open—Timing CML Stem Cell Allografts
American Journal of Hematology, EarlyView.
Jeffrey H. Lipton
wiley +1 more source
ABSTRACT Background Olfactory neuroblastoma (ONB) is a rare sinonasal malignancy primarily treated with surgery. For tumors arising from the olfactory area, traditional treatment involves transcribriform resection of the anterior cranial fossa. Surgery can be performed with unilateral or bilateral resection depending on extent of involvement; however ...
Arash Abiri+35 more
wiley +1 more source
NABIM Wheat allergy and intolerance report [PDF]
MacKenzie, Heather, Venter, Carina
core +1 more source
International Forum of Allergy &Rhinology, Volume 15, Issue 4, Page 441-444, April 2025.
Theodore V. Nguyen+21 more
wiley +1 more source
ABSTRACT Background Type 2 inflammation dominates eosinophilic chronic rhinosinusitis (eCRS) and adult onset asthma. IL‐4, ‐5, and ‐13 are prominent disease mediators. Disease control can be achieved with biologic therapies. However, despite some patients entering remission, others experience poor control. Aim We aimed to describe eCRS patients treated
Peta‐Lee Sacks+8 more
wiley +1 more source
International Forum of Allergy &Rhinology, Volume 15, Issue 5, Page 551-553, May 2025.
Aditi Agarwal+12 more
wiley +1 more source
International Forum of Allergy &Rhinology, Volume 15, Issue 4, Page 445-447, April 2025.
Oloruntobi Rotimi+6 more
wiley +1 more source
International Forum of Allergy &Rhinology, Volume 15, Issue 5, Page 543-546, May 2025.
Max J. Hyman+3 more
wiley +1 more source